Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study

2022-04-11T16:24:18+00:00April 11th, 2022|

Autologous Dendritic Cell-Cytokine Induced Killer Cell Immunotherapy Combined with S-1 Plus Cisplatin in Patients with Advanced Gastric Cancer: A Prospective Study Survival time CONTACT US Summary [...]

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection

2022-02-23T15:21:17+00:00February 23rd, 2022|

Efficacy of adjuvant cytokine-induced killer cell immunotherapy in patients with colorectal cancer after radical resection Duration of chemotherapy CONTACT US Summary The presented study aimed to determine the [...]

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine- induced killer cells in 294 patients

2022-01-18T12:23:08+00:00January 18th, 2022|

Adjuvant treatment for triple-negative breast cancer: a retrospective study of immunotherapy with autologous cytokine- induced killer cells in 294 patients CIK treatment CONTACT US Summary The study aims to [...]

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy

2022-01-13T14:40:02+00:00January 13th, 2022|

Clinical Effect of Adjuvant Cytokine-Induced Killer Cells Immunotherapy in Patients with Stage II-IVB Nasopharyngeal Carcinoma after Chemoradiotherapy Evaluation of the benefits of CIK CONTACT US Summary In this study [...]

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea

2021-12-29T18:31:21+00:00December 29th, 2021|

Phase III randomized trial of autologous cytokine-induced killer cell immunotherapy for newly diagnosed glioblastoma in korea Treatment Scheme CONTACT US Summary The study aims to evaluate the efficacy and [...]

Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies

2021-12-29T18:03:38+00:00December 29th, 2021|

Autologous Cytokine-induced Killer Cell Immunotherapy for Patients with High-Risk Diffuse Large B Cell Lymphoma After the First Complete Remission Overall Survival CONTACT US Summary This study aimed to evaluate [...]

Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies

2021-12-29T17:51:42+00:00December 29th, 2021|

Allogeneic hematopoietic stem cell transplantation following donor CIK cell infusion: A phase I study in patients with relapsed/refractory hematologic malignancies Acute Myeloid leukemia CONTACT US Summary This study aimed [...]

Go to Top